# US 2025/0134934 A1 · Improved methods for decellularizing extracellular matrix (ecm) and preparing decellularized ecm gels and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0134934 A1
- Document ID: US20250134934A1
- Status: Published application
- Kind: A1
- Application number: 18/837,144
- Filed: 2023-02-10
- Published: 2025-05-01
- Earliest claimed: 2022-02-11
- Assignees: RegenX Science, Inc.
- Applicants: RegenX Science, Inc.
- Inventors: Ramon B. Montero; Jun-Hung Cho; Elisabeth A. Corson
- Web page: https://patentgrep.com/patent/US20250134934A1

## CPC

- A61K 35/65: Amphibians, e.g. toads, frogs, salamanders or newts
- A61L 26/0057: {Ingredients of undetermined constitution or reaction products thereof}
- A61K 8/042: {Gels}
- A61K 8/65: Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A61K 8/98: of animal origin
- A61K 8/987: {of species other than mammals or birds}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 26/008: {Hydrogels or hydrocolloids}
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/80: Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61L 2300/30: Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present disclosure describes a novel method for decellularizing amphibian extracellular matrix to obtain an isolated ECM that is substantially free of cellular and nuclear debris. The method includes washing the amphibian ECM in solutions containing one or more surfactants, incubating the ECM with one or more proteases, and incubating the ECM with one or more nucleases. The present disclosure also describes various methods of using the isolated ECM.

## Claims

### Claim 1

A gelatinized ECM in the form of gelatin comprising an isolated amphibian ECM, wherein the isolated amphibian ECM is decellularized and comprises
an intact native ECM structure;
only 1% to 10% or 2% to 10% of the total DNA present in a corresponding native ECM sample;
residual DNA fragments of less than 300 bases (bps) in length, 50 bps to 300 bps in length, or less than 250 bps in length; and/or
greater than 70% or 80% to 90% of its cells removed.

### Claim at position 2

-5. (canceled)

### Claim 6 (depends on 1)

The gelatinized ECM of claim 1, wherein the ECM is obtained from a young amphibian, optionally the young amphibian comprises froglet, tadpole, Urodele, or larval stage young Apoda.

### Claim 7 (depends on 1)

The gelatinized ECM of claim 1, wherein the ECM is obtained from a neotenic Urodele.

### Claim 8 (depends on 1)

A composition comprising the gelatinized ECM of claim 1 and a carrier.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the composition is a pharmaceutical or cosmetic composition, and optionally wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier and wherein the cosmetic composition comprises a cosmetically acceptable carrier.

### Claim 10 (depends on 9)

The composition of claim 9, wherein the composition further comprises one or more agents, and optionally, wherein the one or more agents are xenogenic to the amphibian ECM.

### Claim 11 (depends on 9)

The composition of claim 9, wherein the composition further comprises one or more agents that are peptides, proteins, drugs, nutrients, retinoids, emollients, steroids, carbohydrates, glycoproteins, polymers, or a combination thereof.

### Claim 12 (depends on 9)

The composition of claim 9, wherein the composition further comprises one or more growth factors, cytokines, chemokines, or a combination thereof.

### Claim 13 (depends on 8)

The composition of claim 8, wherein the composition further comprises one or more polymers, and optionally wherein the one or more polymers are synthetic or natural polymers or copolymers.

### Claim 14

A method of decellularizing amphibian ECM, wherein the method comprises harvesting a biological sample from an amphibian, washing the sample with a detergent solution comprising an anionic surfactant, treating the sample with one or more proteases and one or more nucleases to obtain an isolated ECM, and dehydrating the isolated ECM under mild conditions.

### Claim 15 (depends on 15)

The method of claim 15, wherein the method comprises harvesting a biological sample from an amphibian, rinsing the sample with a solution, washing the sample with a detergent solution comprising an anionic surfactant, treating the sample with a protease, rinsing the sample after the protease treatment, and treating the rinsed protease treated sample with a nuclease, to obtain an isolated ECM, and dehydrating the isolated ECM under mild conditions, and optionally, further washing the isolated ECM prior to dehydrating.

### Claim 16 (depends on 15)

The method of claim 15, wherein the method comprises rinsing with water or buffered solution, optionally phosphate buffered saline (PBS) or Dulbecco's phosphate buffered saline (DPBS).

### Claim 17 (depends on 15)

The method of claim 15, wherein the sample is washed with a detergent solution comprising N-lauryl sarcosine (NLS), potassium lauryl sarcosine, cholate, deoxycholate, sodium dodecyl sulfate (SDS), or polyoxyethylene sorbitan fatty acid ester, optionally Tween, 20, 40, 60, or 80.

### Claim 18 (depends on 15)

The method of claim 15, wherein the sample is incubated with one or more proteases comprising one or more amino-endopeptidases, and optionally wherein the one or more proteases comprises dispase I, dispase II, trypsin, papain, and collagenase.

### Claim 19 (depends on 15)

The method of claim 15, wherein the sample is incubated with one or more nucleases comprising a non-specific DNA/RNA endonuclease, and optionally wherein the
one or more nucleases comprising benzonuclease, turbonuclease, pulmozyme, and a combination of DNase and RNase.

### Claim 20 (depends on 15)

The method of claim 15, wherein the method comprises the following steps in the following order:
harvesting a biological sample from an amphibian;
rinsing the sample with buffered saline;
washing the sample with a detergent solution comprising NLS;
rinsing the sample with buffered saline;
treating the rinsed sample with dispase II;
rinsing the sample with buffered saline;
treating the rinsed sample with benzonuclease to obtain an isolated ECM; and
dehydrating the sample under mild conditions;
and optionally, the isolated ECM is washed with DPBS prior to dehydrating under mild conditions.

### Claim 21 (depends on 14)

The method of claim 14, wherein dehydrating under mild conditions comprises dehydrating under vacuum at 15° C. and 360 Torr.

### Claim 22 (depends on 20)

The method of claim 20, wherein the sample is washed with the detergent solution for 6 hours with shaking.

### Claim 23 (depends on 20)

The method of claim 20, wherein in between washing with the detergent solution and treating with protease and between treating with protease and treating with nuclease, the sample is rinsed with DPBS for 5 minutes.

### Claim 24 (depends on 15)

The method of claim 15, wherein the amphibian comprises froglet, tadpole, Urodele, or young larval stage Apoda.

### Claim 25 (depends on 15)

The method of claim 15, wherein the biological sample comprises ECM tissue from a neotenic Urodele.

### Claim 26 (depends on 15)

The method of claim 15, wherein the biological sample comprises ECM of connective tissues, adipose tissue, bone, blood plasma, skin, cartilage, tendon, dura mater, or fascia.

### Claim 27

A method of gelatinizing isolated ECM, wherein the method comprises dissolving the isolated ECM in a solution containing a weak acid and an endopeptidase to form gelatin.

### Claim 28 (depends on 27)

The method of claim 27, wherein the isolated ECM comprises decellularized amphibian ECM comprising
an intact native ECM structure;
only 1% to 10% of the total DNA present in a corresponding native ECM sample;
residual DNA fragments of less than 300 bases (bps); and/or
greater than 70% of its cells removed.

### Claim 29

(canceled)

### Claim 30 (depends on 9)

A method of treating and/or preventing a skin condition, wherein the method comprises administering the composition of claim 9 to a subject in need thereof.

### Claim 31 (depends on 30)

The method of claim 30, wherein the skin condition comprises fine lines and/or wrinkles, aging, redness, abrasion, burns, cuts, infection, razor bumps, scars, uneven skin tone, pain, stretch marks, increasing skin elasticity and/or firmness, improve skin hydration, inflammation, and hyperpigmentation.

### Claim 32 (depends on 30)

The method of claim 30, wherein preventing a skin condition comprises protecting the skin from damages comprising UV rays and/or environmental pollution.
